Item 7. Management’s Discussion and Analysis
ITEM 7. MANAGEMENT'S
DISCUSSION AND ANALYSIS OR PLAN OF OPERATION
The following discussion
and analysis of the results of operations and financial condition of KULR Technology Group, Inc. ("KULR") and its wholly-owned
subsidiary, KULR Technology Corporation (“KTC”) (collectively referred to as “KULR” or the “Company”)
as of and for the years ended December 31, 2020 and 2019 should be read in conjunction with our consolidated financial statements
and the notes to those consolidated financial statements that are included elsewhere in this Annual Report. References in this
Management’s Discussion and Analysis of Financial Condition and Results of Operations to “us”, “we”,
“our” and similar terms refer to the Company. This Management’s Discussion and Analysis of Financial Condition
and Results of Operations contains statements that are forward-looking. These statements are based on current expectations and
assumptions that are subject to risk, uncertainties and other factors. These statements are often identified by the use of words
such as “may,” “will,” “expect,” “believe,” “anticipate,” “intend,”
“could,” “estimate,” or “continue,” and similar expressions or variations. Actual results
could differ materially because of the factors discussed in “Risk Factors” elsewhere in this Annual Report, and other
factors that we may not know.
Overview
KULR Technology Group, Inc.,
through our wholly-owned subsidiary KULR Technology Corporation, develops and commercializes high-performance thermal management
technologies for batteries, electronics, and other components across an array of battery-powered applications. For aerospace and
Department of Defense (“DOD”) applications, our solutions target high performance applications in direct energy, hypersonic
vehicles and satellite communications. For commercial applications, our main focus is a total solution to battery safety and sustainability
by which we aim to mitigate the effects of thermal runaway propagation which has been known to cause random fires in lithium-ion
(“Li-ion”) batteries. This total battery safety solution can be used for electric vehicles, energy storage, battery
recycling transportation, cloud computing and 5G communication devices. Our proprietary core technology is a carbon fiber material
that provides what we believe to be superior thermal conductivity and heat dissipation for an ultra-lightweight and pliable material.
By leveraging our proprietary cooling solutions that have been developed through longstanding partnerships with advanced technology
users like NASA, the Jet Propulsion Lab and others, our products and services make commercial battery powered products safer and
electronics systems cooler and lighter.
KULR’s business
model continues to evolve from being a component supplier, to providing more design and testing services to our customers. The
next step of evolution is to provide total system solutions to address market needs. In order to scale up as a systems provider
more quickly and efficiently in (i) the Li-ion battery energy storage and recycling markets, (ii) battery cell design and safety
testing, and (iii) advanced thermal management systems, such as hypersonic vehicles, KULR will actively seek partners for joint
venture, technology licensing and other strategic partnership models. The goal is to leverage the Company’s thermal design
technology expertise to create market leading products, which KULR will take to market directly to capture more value for KULR
shareholders.
We have not yet achieved
profitability and expect to continue to incur cash outflows from operations, as a result, we will eventually need to generate
significant revenues to achieve profitability. Until that time we shall have to continue to raise cash as and when required through
the sale of stock.
Recent Developments
Paycheck Protection Program Loan
On April 27, 2020, we
received the proceeds of a $155,226 loan in connection with the CARES Act Paycheck Protection Program (PPP) being administered
by the Small Business Administration. The Company believes that it will qualify for loan forgiveness under the terms of the PPP
Agreement.
COVID-19
In January 2020,
an outbreak of a new strain of coronavirus, COVID-19, was identified in Wuhan, China. Through the first quarter of 2020, the disease
became widespread around the world, and on March 11, 2020, the World Health Organization declared a pandemic. Our business
is dependent on developing new markets and new products to be used on a global basis, thus restrictions on travel led to reduced
demand for our products and interruptions to supply chains. Also, the local regulations such as “Shelter in Place”
affected our ability to maintain regular R&D and manufacturing schedules as well as the capability to meet customer demands
in a timely manner. Given the uncertainty around the extent and timing of the potential future spread or mitigation of the Coronavirus
and around the imposition or relaxation of protective measures, we cannot reasonably estimate the impact to our future results
of operations, cash flows, or financial condition.
18
Standby Equity Distribution Agreement
and Notes Payable
On February 27, 2020,
we entered into a Standby Equity Distribution Agreement (“SEDA”) with YAII PN, Ltd., a Cayman Island exempt limited
partnership (“YAII”). Under the terms of this Agreement, the Company raised an aggregate of $2,292,695 from the facility.
As of December 31, 2020, the Company had approximately $5,707,305 available in connection with the SEDA, however, so long as warrants
issued on December 31, 2020 in an unrelated transaction remain outstanding, the Company may not issue shares in connection with
variable rate transactions. During the year ended December 31, 2020, the Company issued notes to YAII in the aggregate amount
of $4,000,000, of which the Company repaid principal on the notes in the aggregate amount of $1,550,000 ($791,000 was repaid from
proceeds from the SEDA). Subsequent to December 31, 2020, the Company repaid principal on the notes in the aggregate amount of
$1,050,000.
Registered Direct Offering
On December 31, 2020, we closed a registered
direct offering conducted pursuant to a securities purchase agreement (“Purchase Agreement”) with the purchasers set
forth on the signature page thereto (the “Purchasers”) for the purchase and sale of an aggregate of 6,400,001 shares
of our common stock (the “Shares”), and warrants to purchase an aggregate of up to 6,400,001 shares of common stock
(“Warrants”), at a combined purchase price of $1.25 per Share and Warrant. The aggregate gross proceeds to us were
equal to approximately $8 million. The Warrants are immediately exercisable and may be exercised at any time until December 31,
2025, at an exercise price of $1.25 per share. Lake Street Capital Markets, LLC and Maxim Group LLC acted as co-placement agents
in connection with the registered direct offering. We paid the co-placement agents a cash fee of 7.0% of the gross proceeds we
received under the Purchase Agreement. We also reimbursed the co-placement agents for certain out-of-pocket accountable expenses
incurred by them in connection with this offering of $50,000. We paid total approximate offering expenses, other than the placement
agent fees, of approximately $170,000, which includes the co-placement agents’ reimbursable expenses, legal, financial advisory
fees, accounting, printing costs, listing fees, and various other expenses associated with registering and issuing the shares.
We intend to use the net proceeds from this offering for capital expenditures, as well as for working capital and general corporate
purposes.
The Shares and Warrants (and underlying shares)
were offered, and will be issued, pursuant to the Prospectus Supplement, dated December 29, 2020, to the Prospectus included in
our Registration Statement on Form S-3 (Registration No. 333- 232614) filed with the Securities and Exchange Commission on July
11, 2019 and declared effective on August 1, 2019.
Appointment of Keith Cochran
On March 8, 2021, our
Board of Directors (the “Board”) appointed Keith Cochran as President and Chief Operating Officer of the Company,
to hold office until the earlier of the expiration of the term of office, a successor is duly elected and qualified, or the earlier
of such officer’s death, resignation, disqualification, or removal.
As compensation for his
services as President and Chief Operating Officer of the Company, Mr. Cochran will receive: (1) a salary of $250,000 per annum
and commensurate benefits; (2) 2,000,000 restricted shares of the Company’s common stock, which shares shall vest, so long
as Mr. Cochran remains employed by the Company, in four (4) equal yearly installments, with the first installment amount to vest
on March 1, 2022 and annually thereafter; and (3) eligibility, also subject to Mr. Cochran’s continued employment with the
Company, for incentive based grants of up to 1,500,000 shares, which shall be earned upon the Company achieving certain market
capitalization milestones.
Appointment of Independent Directors
On February 20, 2021,
the Board, contingent upon the Company’s common stock being approved for uplisting to a national exchange, approved the
appointment of Morio Kurosaki as an independent member of the Board. Mr. Kurosaki will also serve as chair of the Audit Committee.
As such, the Board has determined that Mr. Kurosaki is a financial expert within the meaning of SEC regulations. Additionally,
Mr. Kurosaki will serve as a member of both the Compensation Committee and the Nominating and Governance Committee.
In connection with his
appointments, Mr. Kurosaki will be compensated (1) $10,000 per quarter, beginning on and subject to approval for uplisting, and
(2) 20,000 restricted shares of the Company’s common stock, which shares shall vest equally in 5,000 share increments per
quarter beginning on and subject to approval for uplisting.
19
On February 20, 2021,
the Board, contingent upon the Company’s common stock being approved for uplisting to a national exchange, approved the
appointment of Stayce D. Harris as an independent member of the Board. Ms. Harris will also serve as chair of the Compensation
Committee. Additionally, Ms. Harris will serve as a member of both the Audit Committee and the Nominating and Governance Committee.
In connection with her
appointments, Ms. Harris will be compensated (1) $10,000 per quarter, beginning on and subject to approval for uplisting, and
(2) 20,000 restricted shares of the Company’s common stock, which shares shall vest equally in 5,000 share increments per
quarter beginning on and subject to approval for uplisting.
On February 20, 2021,
the Board, contingent upon the Company’s common stock being approved for uplisting to a national exchange, approved the
appointment of Joanna D. Massey as an independent member of the Board. Ms. Massey will also serve as chair of the Nominating and
Governance Committee. Additionally, Ms. Massey will serve as a member of both the Audit Committee and the Compensation Committee.
.
In connection with her
appointments, and subject to the receipt of her acknowledgment of the same, Ms. Massey will be compensated (1) $10,000 per quarter,
beginning on and subject to approval for uplisting, and (2) 20,000 restricted shares of the Company’s common stock, which
shares shall vest equally in 5,000 share increments per quarter beginning on and subject to approval for uplisting.
Conversion of Series C Preferred Stock
During the year ended
December 31, 2020, KULR issued an aggregate of 56,778 shares of our common stock upon voluntary conversions of 5.11 shares of
our Series C Preferred Stock.
Effective as of December
31, 2020, KULR issued an aggregate of 177,885 shares of our common stock and warrants to purchase an aggregate of 177,885 shares
of our common stock at an exercise price of $1.25 per share, upon a deemed automatic conversion of 18.90 shares of our Series
C Preferred Stock, after which there remained no further Series C Preferred Stock outstanding. Although the conversion shares
were issued subsequent to the deemed automatic conversion, in connection with a registered direct offering that closed on December
31, 2020, the conversions were made effective as of December 31, 2020 pursuant to an automatic conversion feature of the Series
C Preferred Stock under which the stated value of each share was converted into the same securities issued in the registered direct
offering at an effective conversion price of 85% of the aggregate purchase price of such securities.
Conversion of Series B Preferred Stock
During the year ended
December 31, 2020, KULR issued an aggregate of 25,758 shares of our common stock upon conversion of 515 shares of our Series B
Preferred Stock.
Subsequent to the year
ended December 31, 2020, KULR issued an aggregate of 698,600 shares of our common stock upon conversion of 13,972 shares of our
Series B Preferred Stock, after which there remained no further Series B Preferred Stock outstanding.
Consolidated Results of Operations
Year Ended December 31, 2020 Compared
With Year Ended December 31, 2019
Revenue
Our revenues consisted
of the following types:
For the Years Ended
December 31,
2020
2019
Product sales
$ 404,467
$ 735,431
Contract services
219,498
94,967
Total revenue
$ 623,965
$ 830,398
For the years ended December
31, 2020 and 2019, we generated $623,965 and $830,398 of revenues from 25 and 27 customers, respectively, representing a decrease
of $206,433, or 25%. Revenue from product sales during the year ended December 31, 2020 decreased by 45% compared to the year
ended December 31, 2019, primarily due to a large DOD contract of about $355,000 received during the year ended December 31, 2019.
The customer has pushed its next shipment of product to 2021. Product sales during these periods included sales of our component
products, CFV thermal management solutions, ISC battery cells and devices, patented technology, and thermal FTI materials. Revenue
from services increased by 131% for the year ended December 31, 2020 as compared to the year ended December 31, 2019, due to increased
project requirements from some of our new and existing customers. Our service revenues, which include certain research and development
contracts and onsite engineering services, were not hampered by restrictions arising from working under COVID-19 shelter-in-place
regulations.
We are still in the early
stages of business growth and development of customer relationships which typically begin on a project-by-project basis, leading
to limited volume trials and eventually, product sales. As a result, in the absence of a large installed customer base, our sales
can be lumpy and vary from one period to another.
20
Cost of Revenue and Gross Margin
Cost of revenues consisted
of the cost of our products as well as labor expenses directly related to product sales or research contract services.
Generally, we earn greater
margins on revenue from products as compared to revenue from services, so product mix plays an important part in our reported
average margins for any period. Also, we are introducing new products at an early stage in our development cycle and the margins
earned can vary significantly between periods, customers and products due to the learning process, customer negotiating strengths,
and product mix.
Our customers and prospective
customers are large organizations with multiple levels of management, controls/procedures, and contract evaluation/authorization.
Furthermore, our solutions are new and do not necessarily fit into pre-existing patterns of purchase commitment. Accordingly,
the business activity cycle between expression of initial customer interest to shipping, acceptance and billing can be lengthy,
unpredictable and lumpy, which can influence the timing, consistency and reporting of sales growth.
For the years ended December
31, 2020 and 2019, cost of revenues was $169,016 and $226,505, respectively, representing a decrease of $57,489, or 25%. The decrease
was primarily due to reduced costs as a result of reduced revenues. The gross margin percentage was 73% for both of the years
ended December 31, 2020 and 2019.
Research and Development
Research and development
(“R&D”) included expenses incurred in connection with the R&D of our CFV thermal management solution and non-cash
stock-based compensation expenses. R&D expenses are expensed as they are incurred.
For the years ended December
31, 2020 and 2019, R&D expenses were $289,772 and $502,225, respectively, representing a decrease of $212,453 or 42%. The
decrease is attributable to reductions in salaries and other salary related costs, such as payroll taxes and other benefits, implemented
during the end of the first quarter of 2020 due to COVID-19, as well as a reduction in head count between the comparable periods.
We expect that our R&D
expenses will increase as we expand our future operations.
Selling, General and Administrative
Selling, general and administrative
expenses consisted primarily of salaries, payroll taxes and other benefits, legal and professional fees, stock-based compensation,
marketing, travel, rent and office expenses.
For the years ended December
31, 2020 and 2019, selling, general and administrative expenses were $2,505,609 and $2,080,941, respectively, an increase of $424,668,
or 20%. The increase is primarily due to increases of approximately $529,000 for marketing and advertising expense and $262,000
for stock-based compensation related to consultants and employees, partially offset by decreases of approximately $116,000 of
travel, meals, and entertainment expense due to COVID-19 restrictions, $99,000 of rent expense due to the termination of an operating
lease during the end of the fourth quarter of 2019, $30,000 of professional fees, $98,000 of payroll and benefits due to salary
reductions implemented during the end of the first quarter of 2020 as a result of COVID-19, and $17,000 of conference and seminar
expenses due to the travel restrictions and stay-at-home orders as a result of COVID-19.
Other (Expenses) Income
For the years ended December
31, 2020 and 2019, other expenses were $509,664 and $480, respectively, representing an increase of $509,184. The increase is
primarily attributable to the amortization of debt discount recorded in connection with notes payable issued in 2020.
21
Liquidity and Capital Resources
As of December 31, 2020
and 2019, we had cash balances of $8,880,140 and $108,857, respectively, and working capital (deficit) of $6,202,985 and $(824,481),
respectively.
For the years ended December
31, 2020 and 2019, cash used in operating activities was $2,730,253 and $1,188,339, respectively. Our cash used in operations
for the year ended December 31, 2020 was primarily attributable to our net loss of $2,850,096, adjusted for non-cash expenses
in the aggregate amount of $864,929, as well as $754,086 of net cash used to fund changes in the levels of operating assets and
liabilities. Our cash used in operations for the year ended December 31, 2019 was primarily attributable to our net loss of $1,979,753,
adjusted for non-cash expenses in the aggregate amount of $237,990, as well as $553,424 of net cash provided by changes in the
levels of operating assets and liabilities.
For the years ended December
31, 2020 and 2019, cash used in investing activities was $46,087 and $0, respectively. Cash used in investing activities during
the year ended December 31, 2020 was related to the purchases of equipment.
For the years ended December
31, 2020 and 2019, cash provided by financing activities was $11,547,623 and $1,067,300, respectively. Cash provided by financing
activities during the year ended December 31, 2020 was due to the net proceeds from notes payable of $3,710,000, proceeds from
the Paycheck Protection Program loan of $155,226, proceeds from the sale of our common stock pursuant to the SEDA agreement of
$1,501,696, and proceeds from the sale of common stock and warrants received in a public offering of $8,000,001. These amounts
were partially offset by $340,000 for the payment of debt issuance costs, $759,000 for the repayments on notes and $720,300 of
cash paid in offering costs related to sale of our equity securities. Cash provided by financing activities during the year ended
December 31, 2019 was due to the gross proceeds of common stock offering of $898,300 and proceeds from the issuance of our Series
C Convertible Preferred Stock of $184,000, partially offset by cash offering costs paid of $15,000.
Subsequent to December
31, 2020, we made cash payments totaling $1,050,000 to pay down a portion of the outstanding principal due under our notes payable.
We have not yet achieved
profitability and expect to continue to incur cash outflows from operations. It is expected that our research and development
and general and administrative expenses will continue to increase and, as a result, we will eventually need to generate significant
revenues and/or raise additional capital to fund our operations. Although our management believes our current cash on hand is
sufficient to meet our operating and capital requirements for at least the next twelve months from the date these financial statements
are issued, there is no assurance that we will be able to obtain funds on commercially acceptable terms, if at all, on a go-forward
basis. If we are unable to obtain adequate funds on reasonable terms, we may be required to significantly curtail or discontinue
operations or obtain funds by entering into financing agreements on unattractive terms. Our operating needs include the planned
costs to operate our business, including amounts required to fund working capital and capital expenditures.
Our consolidated financial
statements included elsewhere in this Annual Report on Form 10-K have been prepared in conformity with accounting principles generally
accepted in the United States of America (“U.S. GAAP”), which contemplate our continuation as a going concern and
the realization of assets and satisfaction of liabilities in the normal course of business. The carrying amounts of assets and
liabilities presented in the consolidated financial statements do not necessarily purport to represent realizable or settlement
values.
Off-Balance Sheet Arrangements
There are no off-balance
sheet arrangements between us and any other entity that have, or are reasonably likely to have, a current or future effect on
financial conditions, changes in financial conditions, revenues or expenses, results of operations, liquidity, capital expenditures
or capital resources that is material to stockholders.
Critical Accounting Policies
See Note 2 – Summary
of Significant Accounting Policies of our consolidated financial statements included within this Annual Report for our critical
accounting policies.
Recently Issued Accounting Pronouncements
See Note 2 – Summary
of Significant Accounting Policies of our consolidated financial statements included within this Annual Report for a summary of
recently issued and adopted accounting pronouncements.
22
ITEM 7A. QUANTITATIVE AND QUALITATIVE
DISCLOSURES ABOUT MARKET RISK
We are a smaller reporting
company, as defined by Rule 229.10(f)(1) and are not required to provide the information required by this Item.
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY
DATA
See “Index to Consolidated
Financial Statements” which appears on page F-1 of this Annual Report on Form 10-K.
ITEM 9. CHANGES IN AND DISAGREEMENTS
WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
None.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.